Tag: PVI 2024
IVUS is “not a free walk” – it is about the patient...
In conversation with Vascular News about IVUS, Eric Secemsky (Beth Israel Deaconess Medical Center, Boston, USA, and a newly appointed editor of Vascular News...
Drug wars, resorbables and extensive calcification: Maryanne Brodmann delivers a broadside...
Marianne Brodmann (Medical University of Graz, Graz, Austria) shared her opinions on some of the burning debates in peripheral arterial disease (PAD) treatment at...
AI in vascular surgery moves from “dream” realm of research to...
Stéphan Haulon, head of Cardiac and Vascular Surgery, Hôpital Marie Lannelongue, Paris, France, one of the co-directors of the Paris Vascular Insights course (PVI, 12–14...
Sensome announces data from two studies showing clot-sensing guidewire successfully identifies...
Sensome today announced positive results from two studies of its Clotild smart guidewire system demonstrating its ability to successfully identify fresh clot—thrombus rich in...
BIO-OSCAR SOC trial examines standard of care in PAD treatment
Biotronik today announced that it has concluded the BIO-OSCAR SOC study evaluating the baseline against which to measure the Oscar multifunctional catheter in treating complex...
